# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), is pleased to announce that i...
Second Quarter Ended June 30th 2023 Financial Results All figures presented in this section are in Canadian dollars. Cash a...
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to preven...
Liminal BioSciences Inc (NASDAQ: LMNL) shares are trading higher after Structured Alpha, a fund managed by Thomvest Asset Manag...
SALP will acquire all of the issued and outstanding common shares of Liminal BioSciences (the "Common Shares") that it ...
Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), re-confirms that the board of...
Potential shorts squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the ...